The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12103
StudyName: Eligibility Leukemia NCT02225275
Date of export from the portal: 02.07.2020
Date of Upload / last change: 23.09.2015
License: Creative Commons BY 4.0

----

Description: 
Combination of Lenalidomide and Obinutuzumab (GA101) in Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL); ODM derived from: https://clinicaltrials.gov/show/NCT02225275
